CHINA BLUECHEM(03983.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 507.45 million, YoY decrease of 20.78%
NewTimeSpace News: August 19, 2026, CHINA BLUECHEM(03983.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 5.62 billion, decreased by 3.95% YoY; Net Profit stood at CNY 405.73 million, YoY decrease of 43.94%; Profit Attributable to Shareholders stood at CNY 507.45 million, YoY decrease of 20.78%; Basic Earnings Per Share (EPS) stood at CNY 0.11.
In terms of profitability, CHINA BLUECHEM Gross Profit changed from CNY 847.88 million in the same period last year to CNY 798.4 million in the current period, decreased by CNY 49.47 million; gross profit margin changed from 14.49% in the same period last year to 14.21% in the current period, decreased by 0.28 percentage points; net profit changed from CNY 723.77 million in the same period last year to CNY 405.73 million in the current period, decreased by CNY 318.03 million; net profit margin changed from 12.37% in the same period last year to 7.22% in the current period, decreased by 5.15 percentage points.
In terms of earnings quality, CHINA BLUECHEM Operating Profit changed from CNY 634.51 million in the same period last year to CNY 300.31 million in the current period, decreased by CNY 334.2 million; Operating Profit Margin changed from 10.85% in the same period last year to 5.34% in the current period, decreased by 5.5 percentage points.
In terms of financial soundness, CHINA BLUECHEM Debt-to-Asset Ratio changed from 20.35% in the same period last year to 20.32% in the current period, decreased by 0.02 percentage points; Total Equity changed from CNY 19.572 billion in the same period last year to CNY 19.74 billion in the current period, increased by CNY 168.59 million; Current Liabilities changed from CNY 3.2 billion in the same period last year to CNY 3.5 billion in the current period, increased by CNY 293.03 million; Quick Ratio changed from 4.69 in the same period last year to 4.32 in the current period, decreased by 0.37 percentage points.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HJ Science(06132.HK): Stabilisation Period Ends, Over-allotment Option Lapses
- HJ SCIENCE-B(06132.HK) closed 9.79% lower on Jul 17, the Hang Seng Pharmaceuticals & Biotechnology Sector posted broad declines
- HJ SCIENCE-B(06132.HK) closed 15.38% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- HJ SCIENCE-B(06132.HK) closed 38.03% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends